Top

Published in:

01-08-2018 | Critical Care Neurology (K Sheth, Section Editor)

Management of Subdural Hematomas: Part I. Medical Management of Subdural Hematomas

Authors: Elena I. Fomchenko, MD, PhD, Emily J. Gilmore, MD, Charles C. Matouk, MD, Jason L. Gerrard, MD, Kevin N. Sheth, MD

Published in: Current Treatment Options in Neurology | Issue 8/2018

Abstract

Purpose of review

Subdural hematomas (SDH) represent common neurosurgical problem associated with significant morbidity, mortality, and high recurrence rates. SDH incidence increases with age; numbers of patients affected by SDH continue to rise with our aging population and increasing number of people taking antiplatelet agents or anticoagulation. Medical and surgical SDH management remains a subject of investigation.

Recent findings

Initial management of patients with concern for altered mental status with or without trauma starts with Emergency Neurological Life Support (ENLS) guidelines, with a focus on maintaining ICP < 22 mmHg, CPP > 60 mmHg, MAP 80–110 mmHg, and PaO₂ > 60 mmHg, followed by rapid sequence intubation if necessary, and expedited acquisition of imaging to identify a space-occupying lesion. Patients are administered anti-seizure medications, and their antiplatelet medications or anticoagulation may be reversed if neurosurgical interventions are anticipated, or until hemorrhage is stabilized on imaging.

Summary

Medical SDH care focuses on (a) management of intracranial hypertension; (b) maintenance of adequate cerebral perfusion; (c) seizure prevention and treatment; (d) maintenance of normothermia, eucarbia, euglycemia, and euvolemia; and (e) early initiation of enteral feeding, mobilization, and physical therapy. Post-operatively, SDH patients require ICU level care and are co-managed by neurointensivists with expertise in treating increased intracranial pressure, seizures, and status epilepticus, as well as medical complications of critical illness. Here, we review various aspects of medical management with a brief overview of pertinent literature and clinical trials for patients diagnosed with SDH.

Asghar M, Adhiyaman V, Greenway MW, Bhowmick BK, Bates A. Chronic subdural haematoma in the elderly—a North Wales experience. J R Soc Med. 2002 Jun;95(6):290–2.PubMedPubMedCentral

• Balser D, Farooq S, Mehmood T, et al. Actual and projected incidence rates for chronic subdural hematomas in United States veterans administration and civilian populations. J Neurosurg. 2015;123(5):1209–15. A recent study of SDH incidence.CrossRefPubMedPubMedCentral

Bourgeois P, Sleiman M, Louis E, Haddad E, Touzet G, Fichten A, et al. Chronic subdural hematoma in patients over 80 years of age. Neurochirurgie. 1999;45(2):124–8.PubMed

Cousseau DH, Echevarría Martín G, Gaspari M, Gonorazky SE. Chronic and subacute subdural haematoma. An epidemiological study in a captive population. Rev Neurol. 2001;32(9):821–4.PubMed

Kudo H, Kuwamura K, Izawa I, Sawa H, Tamaki N. Chronic subdural hematoma in elderly people: present status on Awaji Island and epidemiological prospect. Neurol Med Chir (Tokyo). 1992;32(4):207–9.CrossRef

Adhiyaman V, Asghar M, Ganeshram KN, Bhowmick BK. Chronic subdural haematoma in the elderly. Postgrad Med J. 2002;78(916):71–5.CrossRefPubMedPubMedCentral

Barlow KM, Minns RA. Annual incidence of shaken impact syndrome in young children. Lancet. 2000;356(9241):1571–2.CrossRefPubMed

Talvik I, Metsvaht T, Leito K, Põder H, Kool P, Väli M, et al. Inflicted traumatic brain injury (ITBI) or shaken baby syndrome (SBS) in Estonia. Acta Paediatr. 2006;95(7):799–804.CrossRefPubMed

Jayawant S, Rawlinson A, Gibbon F, Price J, Schulte J, Sharples P, et al. Subdural haemorrhages in infants: population based study. BMJ. 1998;317(7172):1558–61.CrossRefPubMedPubMedCentral

10.

Sambasivan M. An overview of chronic subdural hematoma: experience with 2300 cases. Surg Neurol. 1997;47(5):418–22.CrossRefPubMed

11.

Tanikawa M, Mase M, Yamada K, Yamashita N, Matsumoto T, Banno T, et al. Surgical treatment of chronic subdural hematoma based on intrahematomal membrane structure on MRI. Acta Neurochir. 2001;143(6):613–8.CrossRefPubMed

12.

Seelig JM, Becker DP, Miller JD, Greenberg RP, Ward JD, Choi SC. Traumatic acute subdural hematoma: major mortality reduction in comatose patients treated within four hours. N Engl J Med. 1981;304(25):1511–8.CrossRefPubMed

13.

Massaro F, Lanotte M, Faccani G, Triolo C. One hundred and twenty-seven cases of acute subdural haematoma operated on. Correlation between CT scan findings and outcome. Acta Neurochir. 1996;138(2):185–91.CrossRefPubMed

14.

Haines DE, Harkey HL, Al-Mefty O. The “subdural” space: a new look at an outdated concept. Neurosurgery. 1993;32(1):111–20.CrossRefPubMed

15.

Sato S, Suzuki J. Ultrastructural observations of the capsule of chronic subdural hematoma in various clinical stages. J Neurosurg. 1975;43(5):569–78.CrossRefPubMed

16.

Yamashima T, Yamamoto S, Friede RL. The role of endothelial gap junctions in the enlargement of chronic subdural hematomas. J Neurosurg. 1983;59(2):298–303.CrossRefPubMed

17.

Lee JY, Ebel H, Ernestus RI, Klug N. Various surgical treatments of chronic subdural hematoma and outcome in 172 patients: is membranectomy necessary? Surg Neurol. 2004;61(6):523–7.CrossRefPubMed

18.

Gennarelli TA, Thibault LE. Biomechanics of acute subdural hematoma. J Trauma. 1982;22(8):680–6.CrossRefPubMed

19.

Haselsberger K, Pucher R, Auer LM. Prognosis after acute subdural or epidural haemorrhage. Acta Neurochir. 1988;90(3–4):111–6.CrossRefPubMed

20.

Maxeiner H, Wolff M. Pure subdural hematomas: a postmortem analysis of their form and bleeding points. Neurosurgery. 2002;50(3):503–8.PubMed

21.

Bullock MR, Chesnut R, Ghajar J, Gordon D, Hartl R, Newell DW, et al. Surgical management of acute subdural hematomas. Surgical Management of Traumatic Brain Injury Author Group. Neurosurgery. 2006;58(3 Suppl):S16–24.PubMed

22.

Servadei F, Nasi MT, Cremonini AM, Giuliani G, Cenni P, Nanni A. Importance of a reliable admission Glasgow Coma Scale score for determining the need for evacuation of posttraumatic subdural hematomas: a prospective study of 65 patients. J Trauma. 1998;44(5):868–73.CrossRefPubMed

23.

Servadei F, Nasi MT, Giuliani G, Cremonini AM, Cenni P, Zappi D, et al. CT prognostic factors in acute subdural haematomas: the value of the ‘worst’ CT scan. Br J Neurosurg. 2000;14(2):110–6.CrossRefPubMed

24.

Schreiber MA, Aoki N, Scott BG, Beck JR. Determinants of mortality in patients with severe blunt head injury. Arch Surg. 2002;137(3):285–90.CrossRefPubMed

25.

Mayer SA, Chong JY. Critical care management of increased intracranial pressure. J Int Care Med. 2002;17(2):55–67.CrossRef

26.

Salvant JB Jr, Muizelaar JP. Changes in cerebral blood flow and metabolism related to the presence of subdural hematoma. Neurosurgery. 1993;33(3):387–93.PubMed

27.

Bergmann M, Puskas Z, Kuchelmeister K. Subdural hematoma due to dural metastasis: case report and review of the literature. Clin Neurol Neurosurg. 1992;94(3):235–40.CrossRefPubMed

28.

Okuno S, Touho H, Ohnishi H, Karasawa J. Falx meningioma presenting as acute subdural hematoma: case report. Surg Neurol. 1999;52(2):180–4.CrossRefPubMed

29.

Beck J, Gralla J, Fung C, Ulrich CT, Schucht P, Fichtner J, et al. Spinal cerebrospinal fluid leak as the cause of chronic subdural hematomas in nongeriatric patients. J Neurosurg. 2014;121(6):1380–7.CrossRefPubMed

30.

Rengachary SS, Szymanski DC. Subdural hematomas of arterial origin. Neurosurgery. 1981 Feb;8(2):166–72.CrossRefPubMed

31.

Inamasu J, Saito R, Nakamura Y, Ichikizaki K, Suga S, Kawase T, et al. Acute subdural hematoma caused by ruptured cerebral aneurysms: diagnostic and therapeutic pitfalls. Resuscitation. 2002;52(1):71–6.CrossRefPubMed

32.

Cowan F, Thoresen M. Changes in superior sagittal sinus blood velocities due to postural alterations and pressure on the head of the newborn infant. Pediatrics. 1985;75(6):1038–47.PubMed

33.

Geddes JF, Tasker RC, Hackshaw AK, Nickols CD, Adams GG, Whitwell HL, et al. Dural haemorrhage in non-traumatic infant deaths: does it explain the bleeding in ‘shaken baby syndrome’? Neuropathol Appl Neurobiol. 2003;29(1):14–22.CrossRefPubMed

34.

Smith MD, Kishikova L, Norris JM. Surgical management of chronic subdural haematoma: one hole or two? Int J Surg. 2012;10(9):450–2.CrossRefPubMed

35.

Anderson CS, Heeley E, Huang Y, Wang J, Stapf C, Delcourt C, et al. INTERACT2 investigators. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368(25):2355–65.CrossRefPubMed

36.

Bratton SL, Chestnut RM, Ghajar J, McConnell Hammond FF, Harris OA, Hartl R, et al. Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons; Joint Section on Neurotrauma and Critical Care, AANS/CNS. Guidelines for the management of severe traumatic brain injury. IX. Cerebral perfusion thresholds. J Neurotrauma. 2007;24(Suppl 1):S59–64.PubMedCrossRef

37.

Elf K, Nilsson P, Ronne-Engström E, Howells T, Enblad P. Cerebral perfusion pressure between 50 and 60 mm Hg may be beneficial in head-injured patients: a computerized secondary insult monitoring study. Neurosurgery. 2005;56(5):962–71.PubMed

38.

Jaeger M, Dengl M, Meixensberger J, Schuhmann MU. Effects of cerebrovascular pressure reactivity-guided optimization of cerebral perfusion pressure on brain tissue oxygenation after traumatic brain injury. Crit Care Med. 2010;38(5):1343–7.CrossRefPubMed

39.

•• Rajajee V, Riggs B, Seder DB. Emergency neurological life support: airway, ventilation, and sedation. Neurocrit Care. 2017;27(Suppl 1):4–28. A summary of critical care guidelines for initial resuscitation of neurologically ill patient.CrossRefPubMed

40.

•• Garvin R, Mangat HS. Emergency neurological life support: severe traumatic brain injury. Neurocrit Care. 2017;27(Suppl 1):159–69. A summary of critical care guidelines for patients with severe traumatic brain injury.CrossRefPubMed

41.

Bateman NT, Leach RM. ABC of oxygen. Acute oxygen therapy. BMJ. 1998;317(7161):798–801.CrossRefPubMedPubMedCentral

42.

Kortbeek JB, Al Turki SA, Ali J, Antoine JA, Bouillon B, Brasel K, et al. Advanced trauma life support, 8th edition, the evidence for change. J Trauma. 2008;64(6):1638–50.CrossRefPubMed

43.

Li J, Murphy-Lavoie H, Bugas C, Martinez J, Preston C. Complications of emergency intubation with and without paralysis. Am J Emerg Med. 1999;17(2):141–3.CrossRefPubMed

44.

Tayal VS, Riggs RW, Marx JA, Tomaszewski CA, Schneider RE. Rapid-sequence intubation at an emergency medicine residency: success rate and adverse events during a two-year period. Acad Emerg Med. 1999;6(1):31–7.CrossRefPubMed

45.

Bernard SA, Nguyen V, Cameron P, Masci K, Fitzgerald M, Cooper DJ, et al. Prehospital rapid sequence intubation improves functional outcome for patients with severe traumatic brain injury: a randomized controlled trial. Ann Surg. 2010;252(6):959–65.CrossRefPubMed

46.

Badri S, Chen J, Barber J, Temkin NR, Dikmen SS, Chesnut RM, et al. Mortality and long-term functional outcome associated with intracranial pressure after traumatic brain injury. Intensive Care Med. 2012;38(11):1800–9.CrossRefPubMed

47.

Verweij BH, Muizelaar JP, Vinas FC. Hyperacute measurement of intracranial pressure, cerebral perfusion pressure, jugular venous oxygen saturation, and laser Doppler flowmetry, before and during removal of traumatic acute subdural hematoma. J Neurosurg. 2001;95(4):569–72.CrossRefPubMed

48.

Coles JP, Minhas PS, Fryer TD, Smielewski P, Aigbirihio F, Donovan T, et al. Effect of hyperventilation on cerebral blood flow in traumatic head injury: clinical relevance and monitoring correlates. Crit Care Med. 2002;30(9):1950–9.CrossRefPubMed

49.

Marion DW, Puccio A, Wisniewski SR, Kochanek P, Dixon CE, Bullian L, et al. Effect of hyperventilation on extracellular concentrations of glutamate, lactate, pyruvate, and local cerebral blood flow in patients with severe traumatic brain injury. Crit Care Med. 2002;30(12):2619–25.CrossRefPubMed

50.

Muizelaar JP, Marmarou A, Ward JD, Kontos HA, Choi SC, Becker DP, et al. Adverse effects of prolonged hyperventilation in patients with severe head injury: a randomized clinical trial. J Neurosurg. 1991;75(5):731–9.CrossRefPubMed

51.

Obrist WD, Langfitt TW, Jaggi JL, Cruz J, Gennarelli TA. Cerebral blood flow and metabolism in comatose patients with acute head injury. Relationship to intracranial hypertension. J Neurosurg. 1984;61(2):241–53.CrossRefPubMed

52.

•• Clinicaltrials.gov. Bethesda (MD): United States National Library of Medicine http://clinicaltrials.gov Accessed April 2018. Comprehensive database of past and ongoing clinical trials.

53.

Andrews PJ, Sinclair HL, Rodriguez A, Harris BA, Battison CG, Rhodes JK, et al. Eurotherm3235 trial collaborators. Hypothermia for intracranial hypertension after traumatic brain injury. N Engl J Med. 2015;373(25):2403–12.CrossRefPubMed

54.

Rabinstein AA, Chung SY, Rudzinski LA, Lanzino G. Seizures after evacuation of subdural hematomas: incidence, risk factors, and functional impact. J Neurosurg. 2010;112(2):455–60.CrossRefPubMed

55.

Sabo RA, Hanigan WC, Aldag JC. Chronic subdural hematomas and seizures: the role of prophylactic anticonvulsive medication. Surg Neurol. 1995;43(6):579–82.CrossRefPubMed

56.

• Carney N, Totten AM, O’Reilly C, Ullman JS, Hawryluk GW, Bell MJ, et al. Guidelines for the management of severe traumatic brain injury, Fourth Edition. Neurosurgery. 2017;80(1):6–15. Additional guidelines for patients with traumatic brain injury.PubMed

57.

Temkin NR, Dikmen SS, Wilensky AJ, Keihm J, Chabal S, Winn HR. A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med. 1990;323(8):497–502.CrossRefPubMed

58.

Schierhout G, Roberts I. Anti-epileptic drugs for preventing seizures following acute traumatic brain injury. Cochrane Database Syst Rev. 2001;4:CD000173.

59.

Ohno K, Maehara T, Ichimura K, Suzuki R, Hirakawa K, Monma S. Low incidence of seizures in patients with chronic subdural haematoma. J Neurol Neurosurg Psychiatry. 1993;56(11):1231–3.CrossRefPubMedPubMedCentral

60.

Rubin G, Rappaport ZH. Epilepsy in chronic subdural haematoma. Acta Neurochir. 1993;123(1–2):39–42.CrossRefPubMed

61.

Inaba K, Menaker J, Branco BC, Gooch J, Okoye OT, Herrold J, et al. A prospective multicenter comparison of levetiracetam versus phenytoin for early posttraumatic seizure prophylaxis. J Trauma Acute Care Surg. 2013;74(3):766–71.CrossRefPubMed

62.

Radic JA, Chou SH, Du R, Lee JW. Levetiracetam versus phenytoin: a comparison of efficacy of seizure prophylaxis and adverse event risk following acute or subacute subdural hematoma diagnosis. Neurocrit Care. 2014;21(2):228–37.CrossRefPubMed

63.

Vespa P, Tubi M, Claassen J, Buitrago-Blanco M, McArthur D, Velazquez AG, et al. Metabolic crisis occurs with seizures and periodic discharges after brain trauma. Ann Neurol. 2016;79(4):579–90.CrossRefPubMed

64.

EpiBioS4Rx. USC Mark and Mary Stevens Neuroimaging and Informatics Institute. http://epibios.loni.usc.edu Accessed April 2018.

65.

Chen CW, Kuo JR, Lin HJ, Yeh CH, Wong BS, Kao CH, et al. Early post-operative seizures after burr-hole drainage for chronic subdural hematoma: correlation with brain CT findings. J Clin Neurosci. 2004;11(7):706–9.CrossRefPubMed

66.

Won SY, Dubinski D, Bruder M, Cattani A, Seifert V, Konczalla J. Acute subdural hematoma in patients on oral anticoagulant therapy: management and outcome. Neurosurg Focus. 2017;43(5):E12.CrossRefPubMed

67.

Grobelny BT, Ducruet AF, Zacharia BE, Hickman ZL, Andersen KN, Sussman E, et al. Preoperative antiepileptic drug administration and the incidence of postoperative seizures following bur hole-treated chronic subdural hematoma. J Neurosurg. 2009;111(6):1257–62.CrossRefPubMed

68.

Ferreri S, Roth MT, Casteel C, Demby KB, Blalock SJ. Methodology of an ongoing, randomized controlled trial to prevent falls through enhanced pharmaceutical care. Am J Geriatr Pharmacother. 2008;6(2):61–81.CrossRefPubMed

69.

Gaist D, García Rodríguez LA, Hellfritzsch M, Poulsen FR, Halle B, Hallas J, et al. Association of antithrombotic drug use with subdural hematoma risk. JAMA. 2017;317(8):836–46.CrossRefPubMed

70.

Wintzen AR, Tijssen JG. Subdural hematoma and oral anticoagulant therapy. Arch Neurol. 1982;39(2):69–72.CrossRefPubMed

71.

• Frontera JA, Lewin JJ 3rd, Rabinstein AA, Aisiku IP, Alexandrov AW, Cook AM, et al. Guideline for reversal of antithrombotics in intracranial hemorrhage: executive summary. A statement for healthcare professionals from the Neurocritical Care Society and the Society of Critical Care Medicine. Crit Care Med. 2016;44(12):2251–7. Thorough review of guidelines for reversal of antithrombotics in patients with intracranial hemorrhage.CrossRefPubMed

72.

Chai-Adisaksopha C, Hillis C, Siegal DM, Movilla R, Heddle N, Iorio A, et al. Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis. Thromb Haemost. 2016;116(5):879–90.CrossRefPubMed

73.

Desborough MJ, Oakland KA, Landoni G, Crivellari M, Doree C, Estcourt LJ, et al. Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta-analysis of randomized controlled trials. J Thromb Haemost. 2017;15(2):263–72.CrossRefPubMed

74.

Narayan RK, Maas AI, Marshall LF, Servadei F, Skolnick BE, Tillinger MN. rFVIIa traumatic ICH study group. Recombinant factor VIIA in traumatic intracerebral hemorrhage: results of a dose-escalation clinical trial. Neurosurgery. 2008;62(4):776–86.CrossRefPubMed

75.

Veshchev I, Elran H, Salame K. Recombinant coagulation factor VIIa for rapid preoperative correction of warfarin-related coagulopathy in patients with acute subdural hematoma. Med Sci Monit. 2002;8(12):CS98–100.PubMed

76.

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, et al. Idarucizumab for dabigatran reversal—full cohort analysis. N Engl J Med. 2017 Aug 3;377(5):431–41.CrossRefPubMed

77.

Ansell JE, Bakhru SH, Laulicht BE, Steiner SS, Grosso M, Brown K, et al. Use of PER977 to reverse the anticoagulant effect of edoxaban. N Engl J Med. 2014;371(22):2141–2.CrossRefPubMed

78.

Siegal DM, Curnutte JT, Connolly SJ, Lu G, Conley PB, Wiens BL, et al. Andexanet alfa for the reversal of factor Xa inhibitor activity. N Engl J Med. 2015;373(25):2413–24.CrossRefPubMed

79.

Garber ST, Sivakumar W, Schmidt RH. Neurosurgical complications of direct thrombin inhibitors--catastrophic hemorrhage after mild traumatic brain injury in a patient receiving dabigatran. J Neurosurg. 2012;116(5):1093–6.CrossRefPubMed

80.

Nishijima DK, Zehtabchi S, Berrong J, Legome E. Utility of platelet transfusion in adult patients with traumatic intracranial hemorrhage and preinjury antiplatelet use: a systematic review. J Trauma Acute Care Surg. 2012;72(6):1658–63.CrossRefPubMedPubMedCentral

81.

Naidech AM, Maas MB, Levasseur-Franklin KE, Liotta EM, Guth JC, Berman M, et al. Desmopressin improves platelet activity in acute intracerebral hemorrhage. Stroke. 2014;45(8):2451–3.CrossRefPubMed

82.

Harhangi BS, Kompanje EJ, Leebeek FW, Maas AI. Coagulation disorders after traumatic brain injury. Acta Neurochir. 2008;150(2):165–75.CrossRefPubMed

83.

Allard CB, Scarpelini S, Rhind SG, Baker AJ, Shek PN, Tien H, et al. Abnormal coagulation tests are associated with progression of traumatic intracranial hemorrhage. J Trauma. 2009;67(5):959–67.CrossRefPubMed

84.

Göksu E, Akyüz M, Uçar T, Kazan S. Spontaneous resolution of a large chronic subdural hematoma: a case report and review of the literature. Ulus Travma Acil Cerrahi Derg. 2009;15(1):95–8.PubMed

85.

Kawamata T, Takeshita M, Kubo O, Izawa M, Kagawa M, Takakura K. Management of intracranial hemorrhage associated with anticoagulant therapy. Surg Neurol. 1995;44(5):438–42.CrossRefPubMed

86.

Stanisic M, Lund-Johansen M, Mahesparan R. Treatment of chronic subdural hematoma by burr-hole craniostomy in adults: influence of some factors on postoperative recurrence. Acta Neurochir. 2005;147(12):1249–56.CrossRefPubMed

87.

Hirsh J, Guyatt G, Albers GW, Harrington R, Schünemann HJ. Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 Suppl):71S–109S.CrossRefPubMed

88.

Torihashi K, Sadamasa N, Yoshida K, Narumi O, Chin M, Yamagata S. Independent predictors for recurrence of chronic subdural hematoma: a review of 343 consecutive surgical cases. Neurosurgery. 2008;63(6):1125–9.CrossRefPubMed

89.

Rust T, Kiemer N, Erasmus A. Chronic subdural haematomas and anticoagulation or anti-thrombotic therapy. J Clin Neurosci. 2006;13(8):823–7.CrossRefPubMed

90.

Yao Z, Hu X, Ma L, You C. Dexamethasone for chronic subdural haematoma: a systematic review and meta-analysis. Acta Neurochir. 2017;159(11):2037–44.CrossRefPubMed

91.

Qian Z, Yang D, Sun F, Sun Z. Risk factors for recurrence of chronic subdural hematoma after burr hole surgery: potential protective role of dexamethasone. Br J Neurosurg. 2017;31(1):84–8.CrossRefPubMed

92.

Delgado-López PD, Martín-Velasco V, Castilla-Díez JM, Rodríguez-Salazar A, Galacho-Harriero AM, Fernández-Arconada O. Dexamethasone treatment in chronic subdural haematoma. Neurocirugia (Astur). 2009;20(4):346–59.CrossRef

93.

Prud'homme M, Mathieu F, Marcotte N, Cottin S. A pilot placebo controlled randomized trial of dexamethasone for chronic subdural hematoma. Can J Neurol Sci. 2016;43(2):284–90.CrossRefPubMed

94.

Emich S, Richling B, McCoy MR, Al-Schameri RA, Ling F, Sun L, et al. The efficacy of dexamethasone on reduction in the reoperation rate of chronic subdural hematoma—the DRESH study: straightforward study protocol for a randomized controlled trial. Trials. 2014;15:6.CrossRefPubMedPubMedCentral

95.

Frati A, Salvati M, Mainiero F, Ippoliti F, Rocchi G, Raco A, et al. Inflammation markers and risk factors for recurrence in 35 patients with a posttraumatic chronic subdural hematoma: a prospective study. J Neurosurg. 2004;100(1):24–32.CrossRefPubMed

96.

Park SH, Kang DH, Park J, Hwang JH, Hwang SK, Sung JK, et al. Fibrinogen and D-dimer analysis of chronic subdural hematomas and computed tomography findings: a prospective study. Clin Neurol Neurosurg. 2011;113(4):272–6.CrossRefPubMed

97.

Schaumann A, Klene W, Rosenstengel C, Ringel F, Tüttenberg J, Vajkoczy P. COXIBRAIN: results of the prospective, randomised, phase II/III study for the selective COX-2 inhibition in chronic subdural haematoma patients. Acta Neurochir. 2016;158(11):2039–44.CrossRefPubMed

98.

Iorio-Morin C, Blanchard J, Richer M, Mathieu D. Tranexamic acid in chronic subdural hematomas (TRACS): study protocol for a randomized controlled trial. Trials 2016;17(1):235.

99.

Drapkin AJ. Chronic subdural hematoma: pathophysiological basis for treatment. Br J Neurosurg. 1991;5(5):467–73.CrossRefPubMed

100.

Jiang R, Wang D, Poon WS, Lu YC, Li XG, Zhao SG, et al. Effect of atorvastatin on chronic subdural hematoma (ATOCH): a study protocol for a randomized controlled trial. Trials. 2015;16:528.CrossRefPubMedPubMedCentral

Title: Management of Subdural Hematomas: Part I. Medical Management of Subdural Hematomas
Authors: Elena I. Fomchenko, MD, PhD
Emily J. Gilmore, MD
Charles C. Matouk, MD
Jason L. Gerrard, MD
Kevin N. Sheth, MD
Publication date: 01-08-2018
Publisher: Springer US
Published in: Current Treatment Options in Neurology / Issue 8/2018
Print ISSN: 1092-8480
Electronic ISSN: 1534-3138
DOI: https://doi.org/10.1007/s11940-018-0517-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Management of Subdural Hematomas: Part I. Medical Management of Subdural Hematomas

Abstract

Purpose of review

Recent findings

Summary

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose of review

Recent findings

Summary

Please log in to get access to this content

Other articles of this Issue 8/2018

What Have We Learned from Recent Clinical Studies in Low-Grade Gliomas?

Current and Emerging Therapies for Duchenne Muscular Dystrophy

Anti-IgLON 5 Disease

Antiplatelet Agents in Secondary Stroke Prevention: Selection, Timing, and Dose

Management of Subdural Hematomas: Part II. Surgical Management of Subdural Hematomas

Treatment of Visual Disorders in Parkinson Disease